Desjardins Global Asset Management Inc. Royalty Pharma PLC Put Options Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding RPRX
# of Institutions
398Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.22 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.05 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$635 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$451 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$330 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...